Ciclosporin implant (Ocumension Therapeutics)

环孢素植入剂（Ocumension Therapeutics）

Report date: 2026/01/21 17:01:07

Base Information

Drug NameCiclosporin implant (Ocumension Therapeutics)
Drug Alias NameCyclosporine implant (Ocumension Therapeutics)OT-1301
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionImmunosuppressantsMitocliondrial permeability transition pore inhibitorsCalcineurin inhibitors +[4] 
TargetsCalcineurinMitocliondrial permeability transition poreP-glycoprotein 1
Therapy Area/IndicationsKeratoplasty rejection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesOcumension Therapeutics (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOcumension Therapeutics (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsKeratoplasty rejection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A